MYC deregulation is involved in the development of a wide variety of cancers [45], BCL2 is dysregulated in many malignancies including breast cancer and gastric carcinoma [46, 47], and NF-κB is implicated in numerous cancers [48]. This evidence concerns the gene BCL2 and breast cancer.